Suppr超能文献

钙结合蛋白II的结构与特性,一种来自人胎盘的抗凝血蛋白。

Structure and properties of calphobindin II, an anticoagulant protein from human placenta.

作者信息

Yoshizaki H, Mizoguchi T, Arai K, Shiratsuchi M, Shidara Y, Maki M

机构信息

Tokyo Research Laboratories, Kowa Co., Ltd.

出版信息

J Biochem. 1990 Jan;107(1):43-50. doi: 10.1093/oxfordjournals.jbchem.a123009.

Abstract

The structure of human placental calphobindin-II (CPB-II) was investigated by amino acid composition and amino acid sequence analyses of peptides generated by protease digestion of the protein. The 45 peptides obtained from the lysyl endopeptidase digest of CPB-II, and the amino-terminal peptide prepared from its tryptic digest, were analyzed, and they accounted for over 98% of total amino acids of CPB-II. The structure of CPB-II determined by protein sequencing was identical to that previously predicted from its cDNA sequence (Iwasaki, A. et al. (1989) J. Biochem. 106, 43-49), except for the amino terminus. Since the amino terminus of CPB-II was blocked to Edman degradation, fast-atom-bombardment mass spectrometric analysis was used to demonstrate that the amino-terminal residue was acetyl-alanine. The carboxyl-terminal residue of CPB-II was identified as aspartic acid by the hydrazinolytic procedure. Calcium-binding studies indicated that 1 mol of CPB II binds 1 mol of calcium in the absence of phospholipid and 8 mol of calcium in the presence of phospholipid.

摘要

通过对人胎盘钙结合蛋白-II(CPB-II)经蛋白酶消化产生的肽段进行氨基酸组成和氨基酸序列分析,研究了其结构。分析了从CPB-II的赖氨酰内肽酶消化产物中获得的45个肽段,以及从其胰蛋白酶消化产物中制备的氨基末端肽段,它们占CPB-II总氨基酸的98%以上。通过蛋白质测序确定的CPB-II结构,除氨基末端外,与先前从其cDNA序列预测的结构相同(岩崎,A.等人(1989年)《生物化学杂志》106卷,43 - 49页)。由于CPB-II的氨基末端对埃德曼降解法呈封闭状态,因此采用快原子轰击质谱分析来证明氨基末端残基是乙酰丙氨酸。通过肼解程序确定CPB-II的羧基末端残基为天冬氨酸。钙结合研究表明,在不存在磷脂的情况下,1摩尔CPB-II结合1摩尔钙,在存在磷脂的情况下结合8摩尔钙。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验